186 related articles for article (PubMed ID: 15931403)
1. Management of hyperlipidaemia.
Stocks N; Allan J; Mansfield PR
Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of CHD.
Nelson MR; Tonkin A
Aust Fam Physician; 2005 Jun; 34(6):433-40. PubMed ID: 15931401
[TBL] [Abstract][Full Text] [Related]
3. Statins for stroke prevention: disappointment and hope.
Amarenco P; Tonkin AM
Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients.
Olyaei A; Greer E; Delos Santos R; Rueda J
Clin J Am Soc Nephrol; 2011 Mar; 6(3):664-78. PubMed ID: 21393488
[TBL] [Abstract][Full Text] [Related]
5. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?
Sever PS
Am J Med; 2005 Dec; 118 Suppl 12A():3-9. PubMed ID: 16356801
[TBL] [Abstract][Full Text] [Related]
7. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
8. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
9. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
Mason CM
J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
[TBL] [Abstract][Full Text] [Related]
10. Management of hyperlipidemia in the elderly population: an evidence-based approach.
Dalal D; Robbins JA
South Med J; 2002 Nov; 95(11):1255-61. PubMed ID: 12539990
[TBL] [Abstract][Full Text] [Related]
11. Management of hyperlipidemia in older adults.
Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
[TBL] [Abstract][Full Text] [Related]
12. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2006 Nov; 98(9):1231-3. PubMed ID: 17056335
[TBL] [Abstract][Full Text] [Related]
13. Treating elevated lipids. Does it make a difference?
Best J; O'Neal D
Aust Fam Physician; 2000 Mar; 29(3):223-6. PubMed ID: 10785987
[TBL] [Abstract][Full Text] [Related]
14. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
Balbisi EA
Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
[TBL] [Abstract][Full Text] [Related]
15. Earlier translation of evidence into public subsidy may prevent morbidity and mortality: an example using statins in diabetics with normal cholesterol levels.
Page MM; Sanfilippo FM; Geelhoed EA; Briffa TG; Hobbs MS
Aust N Z J Public Health; 2012 Oct; 36(5):435-40. PubMed ID: 23025364
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
Ferdinand KC
Curr Med Res Opin; 2005 Jul; 21(7):1091-7. PubMed ID: 16004678
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention, blood cholesterol and statins.
Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
[TBL] [Abstract][Full Text] [Related]
20. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
